Correlation Between Pimco New and Tekla Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pimco New and Tekla Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pimco New and Tekla Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pimco New York and Tekla Life Sciences, you can compare the effects of market volatilities on Pimco New and Tekla Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pimco New with a short position of Tekla Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pimco New and Tekla Life.

Diversification Opportunities for Pimco New and Tekla Life

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pimco and Tekla is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Pimco New York and Tekla Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tekla Life Sciences and Pimco New is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pimco New York are associated (or correlated) with Tekla Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tekla Life Sciences has no effect on the direction of Pimco New i.e., Pimco New and Tekla Life go up and down completely randomly.

Pair Corralation between Pimco New and Tekla Life

Considering the 90-day investment horizon Pimco New York is expected to under-perform the Tekla Life. But the fund apears to be less risky and, when comparing its historical volatility, Pimco New York is 1.88 times less risky than Tekla Life. The fund trades about -0.01 of its potential returns per unit of risk. The Tekla Life Sciences is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  1,164  in Tekla Life Sciences on August 27, 2024 and sell it today you would earn a total of  215.00  from holding Tekla Life Sciences or generate 18.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pimco New York  vs.  Tekla Life Sciences

 Performance 
       Timeline  
Pimco New York 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pimco New York are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. Despite nearly stable basic indicators, Pimco New is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Tekla Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tekla Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Tekla Life is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Pimco New and Tekla Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pimco New and Tekla Life

The main advantage of trading using opposite Pimco New and Tekla Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pimco New position performs unexpectedly, Tekla Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Life will offset losses from the drop in Tekla Life's long position.
The idea behind Pimco New York and Tekla Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated